vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and TripAdvisor, Inc. (TRIP). Click either name above to swap in a different company.
TripAdvisor, Inc. is the larger business by last-quarter revenue ($411.0M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -9.2%, a 105.6% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 0.0%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 2.0%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Tripadvisor is an American company that operates online travel agencies, comparison shopping websites, and mobile apps with user-generated content.
ACAD vs TRIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $411.0M |
| Net Profit | $273.6M | $-38.0M |
| Gross Margin | 90.8% | 91.5% |
| Operating Margin | 6.1% | -8.3% |
| Net Margin | 96.3% | -9.2% |
| Revenue YoY | 9.4% | 0.0% |
| Net Profit YoY | 90.3% | -3900.0% |
| EPS (diluted) | $1.61 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $411.0M | ||
| Q3 25 | $278.6M | $553.0M | ||
| Q2 25 | $264.6M | $529.0M | ||
| Q1 25 | $244.3M | $398.0M | ||
| Q4 24 | $259.6M | $411.0M | ||
| Q3 24 | $250.4M | $532.0M | ||
| Q2 24 | $242.0M | $497.0M | ||
| Q1 24 | $205.8M | $395.0M |
| Q4 25 | $273.6M | $-38.0M | ||
| Q3 25 | $71.8M | $53.0M | ||
| Q2 25 | $26.7M | $36.0M | ||
| Q1 25 | $19.0M | $-11.0M | ||
| Q4 24 | $143.7M | $1.0M | ||
| Q3 24 | $32.8M | $39.0M | ||
| Q2 24 | $33.4M | $24.0M | ||
| Q1 24 | $16.6M | $-59.0M |
| Q4 25 | 90.8% | 91.5% | ||
| Q3 25 | 92.2% | 92.6% | ||
| Q2 25 | 92.2% | 92.1% | ||
| Q1 25 | 91.7% | 93.2% | ||
| Q4 24 | 91.6% | 93.4% | ||
| Q3 24 | 92.5% | 92.5% | ||
| Q2 24 | 92.5% | 92.8% | ||
| Q1 24 | 88.8% | 93.7% |
| Q4 25 | 6.1% | -8.3% | ||
| Q3 25 | 12.8% | 12.7% | ||
| Q2 25 | 12.2% | 11.2% | ||
| Q1 25 | 7.9% | -3.8% | ||
| Q4 24 | 59.1% | 0.2% | ||
| Q3 24 | 12.6% | 13.2% | ||
| Q2 24 | 12.6% | 7.2% | ||
| Q1 24 | 7.4% | -3.8% |
| Q4 25 | 96.3% | -9.2% | ||
| Q3 25 | 25.8% | 9.6% | ||
| Q2 25 | 10.1% | 6.8% | ||
| Q1 25 | 7.8% | -2.8% | ||
| Q4 24 | 55.4% | 0.2% | ||
| Q3 24 | 13.1% | 7.3% | ||
| Q2 24 | 13.8% | 4.8% | ||
| Q1 24 | 8.0% | -14.9% |
| Q4 25 | $1.61 | $-0.32 | ||
| Q3 25 | $0.42 | $0.43 | ||
| Q2 25 | $0.16 | $0.28 | ||
| Q1 25 | $0.11 | $-0.08 | ||
| Q4 24 | $0.86 | $0.03 | ||
| Q3 24 | $0.20 | $0.27 | ||
| Q2 24 | $0.20 | $0.17 | ||
| Q1 24 | $0.10 | $-0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $1.0B |
| Total DebtLower is stronger | — | $819.0M |
| Stockholders' EquityBook value | $1.2B | $645.0M |
| Total Assets | $1.6B | $2.6B |
| Debt / EquityLower = less leverage | — | 1.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $1.0B | ||
| Q3 25 | $258.0M | $1.2B | ||
| Q2 25 | $253.6M | $1.2B | ||
| Q1 25 | $217.7M | $1.2B | ||
| Q4 24 | $319.6M | $1.1B | ||
| Q3 24 | $155.1M | $1.1B | ||
| Q2 24 | $177.1M | $1.2B | ||
| Q1 24 | $204.7M | $1.2B |
| Q4 25 | — | $819.0M | ||
| Q3 25 | — | $821.0M | ||
| Q2 25 | — | $822.0M | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $831.0M | ||
| Q3 24 | — | $832.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $645.0M | ||
| Q3 25 | $917.3M | $707.0M | ||
| Q2 25 | $822.4M | $627.0M | ||
| Q1 25 | $765.2M | $643.0M | ||
| Q4 24 | $732.8M | $943.0M | ||
| Q3 24 | $577.2M | $944.0M | ||
| Q2 24 | $516.7M | $857.0M | ||
| Q1 24 | $464.0M | $825.0M |
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.3B | $2.8B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.1B | $2.8B | ||
| Q4 24 | $1.2B | $2.6B | ||
| Q3 24 | $976.9M | $2.7B | ||
| Q2 24 | $914.1M | $2.8B | ||
| Q1 24 | $855.1M | $2.7B |
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 1.16× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | — | 1.81× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-103.0M |
| Free Cash FlowOCF − Capex | — | $-122.0M |
| FCF MarginFCF / Revenue | — | -29.7% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $163.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-103.0M | ||
| Q3 25 | $74.3M | $44.0M | ||
| Q2 25 | $64.0M | $202.0M | ||
| Q1 25 | $20.3M | $102.0M | ||
| Q4 24 | $40.4M | $-3.0M | ||
| Q3 24 | $63.2M | $-43.0M | ||
| Q2 24 | $25.0M | $51.0M | ||
| Q1 24 | $29.1M | $139.0M |
| Q4 25 | — | $-122.0M | ||
| Q3 25 | $73.9M | $25.0M | ||
| Q2 25 | — | $177.0M | ||
| Q1 25 | — | $83.0M | ||
| Q4 24 | — | $-26.0M | ||
| Q3 24 | $63.2M | $-63.0M | ||
| Q2 24 | — | $36.0M | ||
| Q1 24 | — | $123.0M |
| Q4 25 | — | -29.7% | ||
| Q3 25 | 26.5% | 4.5% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | — | 20.9% | ||
| Q4 24 | — | -6.3% | ||
| Q3 24 | 25.2% | -11.8% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 31.1% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 0.1% | 3.4% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | 0.0% | 3.8% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 0.83× | ||
| Q2 25 | 2.40× | 5.61× | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | -3.00× | ||
| Q3 24 | 1.93× | -1.10× | ||
| Q2 24 | 0.75× | 2.13× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
TRIP
| Third Party | $327.0M | 80% |
| The Fork | $58.0M | 14% |
| Other | $26.0M | 6% |
